Farname Inc. in collaboration with Iranian Society of Gynecology Oncology

Authors

1 Professor, Department of Surgery, General surgeon, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Professor, Department of Urology, urologist, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Professor, Department of Obstetrics and Gynecology, Fellowship of Gynecology Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

4 Fellowship of Gynecology Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

5 Fellowship of Gynecology Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Pelvic exenteration and other type of super-radical procedure is the standard of care in the management of patients with recurrent or persistent cervical cancer. But, since the extent of surgery and possible morbidities are considered as an important challenge in low-resource countries, the present study tries to report the successful outcome of radical surgery in detailed in 7 cases in a low-economic setting. The most valuable point of success is the importance of the multidisciplinary decision, the necessity of experience in this field, psychological consultations with patients, and being prepared for the potential surgical complications. What we had noticed was the excellent survival prognosis even in curative intent. It is highly recommended, considering the psychological effect of such an extensive surgery and quality of life in these patients with advanced disease and loss of hope.

 

 

Keywords

  1. 1. Chew MH, Yeh Y-T, Toh E-L, Sumarli SA, Chew GK, Lee LS, et al. Critical evaluation of contemporary management in a new Pelvic Exenteration Unit: the first 25 consecutive cases. World J Gastrointest Oncol [Internet]. 2017 May 1 [cited 2021 Oct 14];9(5):218–27. Available from: https://researchers.mq.edu.au/en/publications/critical-evaluation-of-contemporary-management-in-a-new-pelvic-ex 2. H B, T M, N T, D L, P M, K H, et al. Detection of extra-regional tumour recurrence with 18 F-FDG-PET/CT in patients with recurrent gynaecological malignancies being considered for radical salvage surgery. Clin Radiol [Internet]. 2017 Apr 1 [cited 2021 Oct 14];72(4):302–6. Available from: https://pubmed.ncbi.nlm.nih.gov/28108013/ 3. GC G, G B, FO F, LY K, CC F, S A, et al. Palliative pelvic exenteration for patients with gynecological malignancies. Arch Gynecol Obstet [Internet]. 2011 May [cited 2021 Oct 14];283(5):1107–12. Available from: https://pubmed.ncbi.nlm.nih.gov/20563730/ 4. Gadducci A, Tana R, … SC-O, 2010 undefined. Treatment options in recurrent cervical cancer. spandidos-publications.com [Internet]. [cited 2020 Dec 6]; Available from: https://www.spandidos-publications.com/10.3892/ol_00000001?text=fulltext 5. JS B, C H, LD L, NF H. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol [Internet]. 2005 Oct [cited 2021 Oct 14];99(1):153–9. Available from: https://pubmed.ncbi.nlm.nih.gov/16054678/ 6. B S, EL J, M K, AL G, NJ L, G C, et al. Influence of tumor size on outcomes following pelvic exenteration. Gynecol Oncol [Internet]. 2017 Nov 1 [cited 2021 Oct 14];147(2):345–50. Available from: https://pubmed.ncbi.nlm.nih.gov/28822555/ 7. C U, R R, D C, C P. [Laparoscopic pelvic exenteration for cervical cancer relapse: preliminary study]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2006 Apr 1 [cited 2021 Oct 14];35(2):136–45. Available from: https://europepmc.org/article/MED/16575359 8. Maharaj R, Sookdeo VD, Fortuné M, Akhilesh M, Venkata CRA, Mohammed W, et al. Pelvic exenteration case series: A single surgeon’s experience at one institution in Trinidad and Tobago. Int J Surg Case Rep [Internet]. 2017 [cited 2021 Oct 14];34:4. Available from: /pmc/articles/PMC5358951/ 9. AM S, P I, D F, H E. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol [Internet]. 2012 Jun [cited 2021 Oct 14];125(3):604–9. Available from: https://pubmed.ncbi.nlm.nih.gov/22406639/ 10. JM Y, T B-P, LM M, M K, C K, AC L, et al. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. Br J Surg [Internet]. 2014 Feb [cited 2021 Oct 14];101(3):277–87. Available from: https://pubmed.ncbi.nlm.nih.gov/24420909/ 11. AJ Q, MJ S, PM L, T B-P, LM M, JM Y. Palliative Pelvic Exenteration: Clinical Outcomes and Quality of Life. Dis Colon Rectum [Internet]. 2016 Nov 1 [cited 2021 Oct 14];59(11):1005–10. Available from: https://pubmed.ncbi.nlm.nih.gov/27749474/ 12. Donati OF, Lakhman Y, Sala E, Burger IA, Vargas HA, Goldman DA, et al. Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration. Eur Radiol. 2013 Oct;23(10):2906–15. 13. WE B, CE K, T B-P, MJ S. Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer. Dis Colon Rectum [Internet]. 2017 Feb 1 [cited 2021 Oct 14];60(2):144–51. Available from: https://europepmc.org/article/med/28059910 14. Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, et al. Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecol Oncol [Internet]. 2018 Jun 1 [cited 2021 Oct 14];149(3):484. Available from: /pmc/articles/PMC5986607/